(Q25257685)

6 July 2017

title

CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response (English)

1 reference

6 July 2017

0 references

Pia P Wegman

1

1 reference

6 July 2017

Sten Wingren

series ordinal

2

1 reference

6 July 2017

language of work or name

English

0 references

publication date

29 March 2005

1 reference

6 July 2017

published in

Breast Cancer Research

1 reference

6 July 2017

volume

7

1 reference

6 July 2017

issue

6

1 reference

6 July 2017

page(s)

E7

1 reference

CYP2D6 genotype and tamoxifen response

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410755

PubMed Central

reference URL

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410755

PubMed Central

reference URL

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410755

PubMed Central

reference URL

28 September 2017

Identifiers

DOI

10.1186/BCR1326

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference